Forbes, March 1, 2016. Diana Zuckerman of The National Center for Health Research reports that “women and their doctors have been terribly misinformed about the complications [of Essure contraceptive], and that misinformation has greatly added to women’s suffering.”
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Federal Health Regulators Plan to Warn Consumers More Strongly About Essure
U.S. News and World Report, February 29, 2016. With FDA’s plan to warn consumers about the birth contraceptive implant Essure, Diana Zuckerman at The National Center for Health Research shares: “We strongly support a black box warning, but it needs to be a very strong one.”
Read More »Birth Control Device Slapped with Warnings About Dangerous Side Effects
Buzzfeed, February 29. 2016. After months of debate, the FDA is acknowledging the serious risks that come with the Essure sterilization device. But many women are angry it hasn’t been pulled from the market.
Read More »FDA Recommends Black Box on Essure, Says It Requires Further Study
Modern Health, February 29, 2016. National Center for Health Research’s president Dr. Diana Zuckerman advises that the warning label on Essure implant contraceptive and the studies to be performed on Essure by Bayer, the company that makes the product, must both be under close watch.
Read More »Critics See Accountability Risk If FDA Rule Changes Take Hold
Star Tribune, February 14, 2016. A move to relax labeling requirements for drugs and medical devices has some patient advocates concerned that people will have a tougher time holding manufacturers accountable for injuries caused by their products.
Read More »